Literature DB >> 1939641

Influence of apolipoprotein E polymorphism on apolipoprotein B-100 metabolism in normolipemic subjects.

T Demant1, D Bedford, C J Packard, J Shepherd.   

Abstract

This study examined apolipoprotein (apo) B metabolism in normolipemic subjects homozygous for the apo E2 (n = 4), apo E3 (n = 5), or apo E4 (n = 5) phenotype. Radioiodinated very low density lipoprotein (VLDL1) (ultracentrifuge flotation rate [Sf] 60-400) and VLDL2 (Sf 20-60) were injected into volunteers and the conversion of apo B was followed through intermediate density lipoprotein (IDL) to low density lipoprotein (LDL). Subjects homozygous for E3 converted approximately 50% of LVDL2 to LDL, the remainder being lost by direct catabolism. Those with the E2 phenotype produced less VLDL1, but converted more of it to VLDL2 (compared to E3 subjects). They displayed a characteristic dyslipidemia with the presence of slowly catabolized VLDL1 and VLDL2 remnants. LDL levels were low owing to increased direct catabolism of VLDL2 and IDL and a reduced efficiency of delipidation; only 25% of VLDL2 apo B was directed to LDL production. In contrast, E4 subjects converted more VLDL2 apo B to LDL than E3 subjects. About 70% of VLDL2 apo B was found in LDL; direct catabolism of VLDL and IDL was reduced as was the fractional catabolic rate of LDL (0.2 vs. 0.26 in E3 subjects). These changes in the VLDL----IDL----LDL metabolic cascade can in part be explained by alterations in hepatic LDL receptors with E2 subjects having higher and E4 subjects lower activities than those in E3 homozygotes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1939641      PMCID: PMC295655          DOI: 10.1172/JCI115459

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Apolipoprotein B metabolism in homozygous familial hypercholesterolemia.

Authors:  R W James; B Martin; D Pometta; J C Fruchart; P Duriez; P Puchois; J P Farriaux; A Tacquet; T Demant; R J Clegg
Journal:  J Lipid Res       Date:  1989-02       Impact factor: 5.922

3.  The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations.

Authors:  D W Bilheimer; S Eisenberg; R I Levy
Journal:  Biochim Biophys Acta       Date:  1972-02-21

4.  Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype.

Authors:  Y A Kesäniemi; C Ehnholm; T A Miettinen
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

5.  Lipoprotein metabolism in hepatic lipase deficiency: studies on the turnover of apolipoprotein B and on the effect of hepatic lipase on high density lipoprotein.

Authors:  T Demant; L A Carlson; L Holmquist; F Karpe; P Nilsson-Ehle; C J Packard; J Shepherd
Journal:  J Lipid Res       Date:  1988-12       Impact factor: 5.922

6.  Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E.

Authors:  M S Weintraub; S Eisenberg; J L Breslow
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

7.  Lipoprotein metabolism during acute inhibition of lipoprotein lipase in the cynomolgus monkey.

Authors:  I J Goldberg; N A Le; H N Ginsberg; R M Krauss; F T Lindgren
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

Review 8.  Apolipoprotein E polymorphism and atherosclerosis.

Authors:  J Davignon; R E Gregg; C F Sing
Journal:  Arteriosclerosis       Date:  1988 Jan-Feb

9.  Catabolism of chylomicron remnants in normolipidemic subjects in relation to the apoprotein E phenotype.

Authors:  B J Brenninkmeijer; P M Stuyt; P N Demacker; A F Stalenhoef; A van 't Laar
Journal:  J Lipid Res       Date:  1987-04       Impact factor: 5.922

10.  Surface location and high affinity for calcium of a 500-kd liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor.

Authors:  J Herz; U Hamann; S Rogne; O Myklebost; H Gausepohl; K K Stanley
Journal:  EMBO J       Date:  1988-12-20       Impact factor: 11.598

View more
  23 in total

1.  Apolipoprotein E4 domain interaction accelerates diet-induced atherosclerosis in hypomorphic Arg-61 apoe mice.

Authors:  Delphine Eberlé; Roy Y Kim; Fu Sang Luk; Nabora Soledad Reyes de Mochel; Nathalie Gaudreault; Victor R Olivas; Nikit Kumar; Jessica M Posada; Andrew C Birkeland; Joseph H Rapp; Robert L Raffai
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-03-22       Impact factor: 8.311

2.  Heritability of longitudinal changes in coronary-heart-disease risk factors in women twins.

Authors:  Y Friedlander; M A Austin; B Newman; K Edwards; E I Mayer-Davis; M C King
Journal:  Am J Hum Genet       Date:  1997-06       Impact factor: 11.025

3.  Apo E structure determines VLDL clearance and atherosclerosis risk in mice.

Authors:  C Knouff; M E Hinsdale; H Mezdour; M K Altenburg; M Watanabe; S H Quarfordt; P M Sullivan; N Maeda
Journal:  J Clin Invest       Date:  1999-06       Impact factor: 14.808

4.  Interactive effects of APOE haplotype, sex, and exercise on postheparin plasma lipase activities.

Authors:  Richard L Seip; Robert F Zoeller; Theodore J Angelopoulos; James Salonia; Cherie Bilbie; Niall M Moyna; Mary P Miles; Paul S Visich; Linda S Pescatello; Paul M Gordon; Gregory J Tsongalis; Linda Bausserman; Paul D Thompson
Journal:  J Appl Physiol (1985)       Date:  2011-01-20

5.  Effects of the apolipoprotein E polymorphism on uptake and transfer of cell-derived cholesterol in plasma.

Authors:  Y Huang; A von Eckardstein; S Wu; G Assmann
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

6.  Apolipoprotein E gene polymorphism in nonalcoholic fatty liver disease.

Authors:  Mehmet Derya Demirag; Hacer Ilke Onen; Meral Yirmibes Karaoguz; Ibrahim Dogan; Tarkan Karakan; Abdullah Ekmekci; Galip Guz
Journal:  Dig Dis Sci       Date:  2007-04-12       Impact factor: 3.199

7.  Structural variation in human apolipoprotein E3 and E4: secondary structure, tertiary structure, and size distribution.

Authors:  Chi-Yuan Chou; Yi-Ling Lin; Yu-Chyi Huang; Sheh-Yi Sheu; Ta-Hsien Lin; Huey-Jen Tsay; Gu-Gang Chang; Ming-Shi Shiao
Journal:  Biophys J       Date:  2004-10-08       Impact factor: 4.033

8.  The effect of the apolipoprotein E phenotype on plasma lipids is not influenced by environmental variability: results of a Dutch twin study.

Authors:  P de Knijff; D I Boomsma; E de Wit; H J Kempen; J A Gevers Leuven; R R Frants; L M Havekes
Journal:  Hum Genet       Date:  1993-04       Impact factor: 4.132

9.  Effect of pravastatin on metabolic parameters of apolipoprotein B in patients with mixed hyperlipoproteinemia.

Authors:  K G Parhofer; P H Barrett; J Dunn; G Schonfeld
Journal:  Clin Investig       Date:  1993-11

10.  Apolipoprotein E phenotype and lipoprotein(a) in familial hypercholesterolaemia: implication for lipoprotein(a) metabolism.

Authors:  G Lindahl; F Mailly; S Humphries; M Seed
Journal:  Clin Investig       Date:  1994-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.